DEVELOPMENT OF A HUMAN LYMPHOBLASTOID CELL-LINE CONSTITUTIVELY EXPRESSING HUMAN CYP1A1 CDNA - SUBSTRATE-SPECIFICITY WITH MODEL SUBSTRATES AND PROMUTAGENS

被引:54
作者
PENMAN, BW
CHEN, LP
GELBOIN, HV
GONZALEZ, FJ
CRESPI, CL
机构
[1] GENTEST CORP, WOBURN, MA 01801 USA
[2] NCI, MOLEC CARCINOGENESIS LAB, BETHESDA, MD 20892 USA
关键词
D O I
10.1093/carcin/15.9.1931
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AHH-1 TK+/- cell derivatives were developed that stably express human CYP1A1 cDNA, and an AHH-1 TK+/- derivative expressing higher levels of CYP1A2 cDNA in extrachromosomal vectors which confer resistance to 1-histidinol. The CYP1A1-expressing cell lines, designated h1A1 and h1A1v2 differ by containing one and two CYP1A1 cDNA expression units per vector. The CYP1A2-expressing cell line, designated h1A2v2, also has two CYP1A2 cDNA expression units per vector. Microsomes prepared from CYP1A1 cDNA expressing cells exhibit high, constitutive levels of 7-ethoxyresorufin deethylase (EROD), 7-ethoxycoumarin deethylase (ECD), 7-ethoxy-4-trifluoromethylcoumarin deethylase (EFCD), benzo[a]pyrene hydroxylase (BPH) activities and spectrally quantifiable cytochrome P450. Kinetic comparisons between cDNA-expressed CYP1A1 and CYP1A2 indicate that CYP1A1 is more active than CYP1A1, for EROD, ECD, EFCD and BPH. CYP1A2 was more active than CYP1A1 for acetanilide hydroxylation and activation of affatoxin B-1 (AFB1). The mutagenicity of selected promutagens were examined in h1A1 cells and control cells. Relative to control cells, the h1A1 cell line exhibits increased sensitivity to the mutagenicity of benzo[a]pyrene, cyclopenta[c,d]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and AFB(1).
引用
收藏
页码:1931 / 1937
页数:7
相关论文
共 45 条
[1]   5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1 [J].
AOYAMA, T ;
YAMANO, S ;
GUZELIAN, PS ;
GELBOIN, HV ;
GONZALEZ, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4790-4793
[2]  
BURKE MD, 1977, DRUG METAB DISPOS, V5, P1
[3]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[4]   THE INDUCTION OF ANEUPLOIDY BY NITROGEN-MUSTARD IN A HUMAN-LYMPHOBLASTOID CELL-LINE [J].
CRESPI, CL ;
SEIXAS, GM ;
PENMAN, BW .
MUTATION RESEARCH, 1987, 190 (01) :69-76
[5]   A TOBACCO SMOKE-DERIVED NITROSAMINE, 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, IS ACTIVATED BY MULTIPLE HUMAN CYTOCHROME P450S INCLUDING THE POLYMORPHIC HUMAN CYTOCHROME P4502D6 [J].
CRESPI, CL ;
PENMAN, BW ;
GELBOIN, HV ;
GONZALEZ, FJ .
CARCINOGENESIS, 1991, 12 (07) :1197-1201
[6]   THE DEVELOPMENT OF A HUMAN CELL-LINE STABLY EXPRESSING HUMAN CYP3A4 - ROLE IN THE METABOLIC-ACTIVATION OF AFLATOXIN-B1 AND COMPARISON TO CYP1A2 AND CYP2A3 [J].
CRESPI, CL ;
PENMAN, BW ;
STEIMEL, DT ;
GELBOIN, HV ;
GONZALEZ, FJ .
CARCINOGENESIS, 1991, 12 (02) :355-359
[7]   STABLE EXPRESSION OF HUMAN CYTOCHROME-P450IA2 CDNA IN A HUMAN LYMPHOBLASTOID CELL-LINE - ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF AFLATOXIN-B1 [J].
CRESPI, CL ;
STEIMEL, DT ;
AOYAMA, T ;
GELBOIN, HV ;
GONZALEZ, FJ .
MOLECULAR CARCINOGENESIS, 1990, 3 (01) :5-8
[8]   XENOBIOTIC METABOLISM AND MUTATION IN A HUMAN-LYMPHOBLASTOID CELL-LINE [J].
CRESPI, CL ;
ALTMAN, JD ;
MARLETTA, MA .
CHEMICO-BIOLOGICAL INTERACTIONS, 1985, 53 (03) :257-271
[9]   HUMAN CYTOCHROME P450IIA3 - CDNA SEQUENCE, ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF PROMUTAGENS, COMPARISON TO NITROSAMINE ACTIVATION BY HUMAN CYTOCHROME P450IIE1 [J].
CRESPI, CL ;
PENMAN, BW ;
LEAKEY, JAE ;
ARLOTTO, MP ;
STARK, A ;
PARKINSON, A ;
TURNER, T ;
STEIMEL, DT ;
RUDO, K ;
DAVIES, RL ;
LANGENBACH, R .
CARCINOGENESIS, 1990, 11 (08) :1293-1300
[10]   TRANSFECTION OF A HUMAN CYTOCHROME-P-450 GENE INTO THE HUMAN-LYMPHOBLASTOID CELL-LINE, AHH-1, AND USE OF THE RECOMBINANT CELL-LINE IN GENE MUTATION ASSAYS [J].
CRESPI, CL ;
LANGENBACH, R ;
RUDO, K ;
CHEN, YT ;
DAVIES, RL .
CARCINOGENESIS, 1989, 10 (02) :295-301